X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with Dishman Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs DISHMAN PHARMA - Comparison Results

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB DISHMAN PHARMA UNICHEM LAB/
DISHMAN PHARMA
 
P/E (TTM) x 22.4 25.1 89.2% View Chart
P/BV x 2.4 3.3 70.4% View Chart
Dividend Yield % 0.8 0.7 121.4%  

Financials

 UNICHEM LAB   DISHMAN PHARMA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-16
DISHMAN PHARMA
Mar-16
UNICHEM LAB/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs334374 89.2%   
Low Rs174129 135.0%   
Sales per share (Unadj.) Rs146.9197.8 74.3%  
Earnings per share (Unadj.) Rs11.921.2 56.1%  
Cash flow per share (Unadj.) Rs16.234.7 46.6%  
Dividends per share (Unadj.) Rs2.002.00 100.0%  
Dividend yield (eoy) %0.80.8 99.1%  
Book value per share (Unadj.) Rs105.1179.9 58.4%  
Shares outstanding (eoy) m90.8480.69 112.6%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.71.3 135.9%   
Avg P/E ratio x21.411.9 180.0%  
P/CF ratio (eoy) x15.77.2 216.5%  
Price / Book Value ratio x2.41.4 172.7%  
Dividend payout %16.89.4 178.3%   
Avg Mkt Cap Rs m23,07320,306 113.6%   
No. of employees `0005.70.8 684.3%   
Total wages/salary Rs m2,5585,355 47.8%   
Avg. sales/employee Rs Th2,352.519,252.7 12.2%   
Avg. wages/employee Rs Th450.96,459.5 7.0%   
Avg. net profit/employee Rs Th190.42,064.1 9.2%   
INCOME DATA
Net Sales Rs m13,34615,961 83.6%  
Other income Rs m192265 72.3%   
Total revenues Rs m13,53816,226 83.4%   
Gross profit Rs m1,6394,103 39.9%  
Depreciation Rs m3901,091 35.8%   
Interest Rs m29944 3.0%   
Profit before tax Rs m1,4122,334 60.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m-41 -336.4%   
Extraordinary Inc (Exp) Rs m-350-   
Tax Rs m293624 46.9%   
Profit after tax Rs m1,0801,711 63.1%  
Gross profit margin %12.325.7 47.8%  
Effective tax rate %20.726.7 77.6%   
Net profit margin %8.110.7 75.5%  
BALANCE SHEET DATA
Current assets Rs m5,97911,018 54.3%   
Current liabilities Rs m2,4329,517 25.6%   
Net working cap to sales %26.69.4 282.7%  
Current ratio x2.51.2 212.4%  
Inventory Days Days63110 57.1%  
Debtors Days Days6035 173.3%  
Net fixed assets Rs m6,40316,304 39.3%   
Share capital Rs m182161 112.6%   
"Free" reserves Rs m9,29312,907 72.0%   
Net worth Rs m9,54814,516 65.8%   
Long term debt Rs m2304,189 5.5%   
Total assets Rs m12,84329,805 43.1%  
Interest coverage x50.03.5 1,441.4%   
Debt to equity ratio x00.3 8.4%  
Sales to assets ratio x1.00.5 194.1%   
Return on assets %8.68.9 96.9%  
Return on equity %11.311.8 96.0%  
Return on capital %14.317.5 81.8%  
Exports to sales %29.224.8 117.9%   
Imports to sales %6.33.7 169.8%   
Exports (fob) Rs m3,9003,956 98.6%   
Imports (cif) Rs m847596 142.0%   
Fx inflow Rs m4,3564,952 88.0%   
Fx outflow Rs m1,162697 166.8%   
Net fx Rs m3,1944,255 75.1%   
CASH FLOW
From Operations Rs m1,1192,786 40.2%  
From Investments Rs m-853-1,529 55.8%  
From Financial Activity Rs m-334-941 35.5%  
Net Cashflow Rs m-68316 -21.6%  

Share Holding

Indian Promoters % 50.1 61.4 81.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 3.7 408.1%  
FIIs % 3.0 12.7 23.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 22.1 143.4%  
Shareholders   20,176 46,261 43.6%  
Pledged promoter(s) holding % 0.0 35.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   WOCKHARDT LTD.  TTK HEALTHCARE  MERCK LTD  BIOCON LTD  FULFORD INDIA  

Compare UNICHEM LAB With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Weak Finish to the Week Post Vishal Sikka's Exit as CEO of Infosys(Closing)

Share markets in India witnessed selling pressure, led by slump in shares of Infosys Ltd. after Vishal Sikka resigned as chief executive officer of the country's second-largest software services exporter.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Aug 18, 2017 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB - CADILA HEALTHCARE COMPARISON

COMPARE UNICHEM LAB WITH

MARKET STATS